R&D, Pharmacovigilance & Regulatory Affairs

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

Title Location Date Sort ascending Req ID
Reset
Clinical Program Leader
Clinical Program Leader Cary, NC, US Mar 13, 2026 7017
Cary, NC, US Mar 13, 2026 7017
Master's thesis in computational modelling of aerosol deposition in respiratory system Parma, IT Mar 13, 2026 6598
Senior Director, Clinical Biometrics & Analytics Parma, IT Mar 13, 2026 6387
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT Mar 17, 2026 6111
Clinical Program Leader, Neonatology & Care
Clinical Program Leader, Neonatology & Care Europe, IT Mar 20, 2026 6955
Europe, IT Mar 20, 2026 6955
Clinical Research Physician, Rare Disease
Clinical Research Physician, Rare Disease Europe - remote, IT Mar 23, 2026 7087
Europe - remote, IT Mar 23, 2026 7087
Medical Information & PV Officer
Medical Information & PV Officer Zaventem, BE Mar 25, 2026 7089
Zaventem, BE Mar 25, 2026 7089
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT Mar 28, 2026 5993
PARMA, IT Mar 28, 2026 5993
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE Apr 5, 2026 351
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT Apr 9, 2026 6592